Market Research

Preterm Birth and PROM Testing Market (Test Type: Preterm Birth Tests and PROM Tests: End-user: Hospitals, Diagnostic Laboratories, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 165 Pages Transparency Market Research Pvt. Ltd. March, 2024 TNPR18769939
Best Price Guarantee
Price from $5,795
Length 165 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date March, 2024
SKU TNPR18769939

Preterm Birth and PROM Testing Market (Test Type: Preterm Birth Tests and PROM Tests: End-user: Hospitals, Diagnostic Laboratories, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034


Preterm Birth and PROM Testing Market – Scope of Report

TMR’s report on the global preterm birth and PROM testing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global preterm birth and PROM testing market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global preterm birth and PROM testing market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the preterm birth and PROM testing market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global preterm birth and PROM testing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global preterm birth and PROM testing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global preterm birth and PROM testing market.

The report delves into the competitive landscape of the global preterm birth and PROM testing market. Key players operating in the global preterm birth and PROM testing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global preterm birth and PROM testing market profiled in this report.

Key Questions Answered in Global preterm birth and PROM testing Market Report
  • What is the sales/revenue generated by preterm birth and PROM testing across all regions during the forecast period?
  • What are the opportunities in the global preterm birth and PROM testing market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Preterm Birth and PROM Testing Market – Research Objectives and Research Approach

The comprehensive report on the global preterm birth and PROM testing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global preterm birth and PROM testing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global preterm birth and PROM testing market.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Preterm Birth and PROM Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Preterm Birth and PROM Testing Market Analysis and Forecast, 2020 - 2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Preterm Birth and PROM Testing Market Analysis and Forecast, by Test Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Test Type, 2020 - 2034
6.3.1. Preterm Birth Tests
6.3.1.1. Pelvic Exam
6.3.1.2. Ultrasound
6.3.1.3. Uterine Monitoring
6.3.1.4. Biomarker
6.3.2. PROM Tests
6.3.2.1. Nitrazine Test
6.3.2.2. Ferning Test
6.3.2.3. Pooling
6.3.2.4. Ultrasound
6.3.2.5. Fetal Fibronectin Test
6.3.2.6. Biomarker Test
6.3.2.7. Others
6.4. Market Attractiveness Analysis, by Test Type
7. Global Preterm Birth and PROM Testing Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2020 - 2034
7.3.1. Hospitals
7.3.2. Diagnostics Laboratories
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Preterm Birth and PROM Testing Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2020 - 2034
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Preterm Birth and PROM Testing Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Test Type, 2020 - 2034
9.3.1. Preterm Birth Tests
9.3.1.1. Pelvic Exam
9.3.1.2. Ultrasound
9.3.1.3. Uterine Monitoring
9.3.1.4. Biomarker
9.3.2. PROM Tests
9.3.2.1. Nitrazine Test
9.3.2.2. Ferning Test
9.3.2.3. Pooling
9.3.2.4. Ultrasound
9.3.2.5. Fetal Fibronectin Test
9.3.2.6. Biomarker Test
9.3.2.7. Others
9.4. Market Value Forecast, by End-user, 2020 - 2034
9.4.1. Hospitals
9.4.2. Diagnostics Laboratories
9.4.3. Others
9.5. Market Value Forecast, by Country, 2020 - 2034
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Test Type
9.6.2. By End-user
9.6.3. By Country
10. Europe Preterm Birth and PROM Testing Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Test Type, 2020 - 2034
10.3.1. Preterm Birth Tests
10.3.1.1. Pelvic Exam
10.3.1.2. Ultrasound
10.3.1.3. Uterine Monitoring
10.3.1.4. Biomarker
10.3.2. PROM Tests
10.3.2.1. Nitrazine Test
10.3.2.2. Ferning Test
10.3.2.3. Pooling
10.3.2.4. Ultrasound
10.3.2.5. Fetal Fibronectin Test
10.3.2.6. Biomarker Test
10.3.2.7. Others
10.4. Market Value Forecast, by End-user, 2020 - 2034
10.4.1. Hospitals
10.4.2. Diagnostics Laboratories
10.4.3. Others
10.5. Market Value Forecast, by Country/Sub-region, 2020 - 2034
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Test Type
10.6.2. By End-user
10.6.3. By Country/Sub-region
11. Asia Pacific Preterm Birth and PROM Testing Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Test Type, 2020 - 2034
11.3.1. Preterm Birth Tests
11.3.1.1. Pelvic Exam
11.3.1.2. Ultrasound
11.3.1.3. Uterine Monitoring
11.3.1.4. Biomarker
11.3.2. PROM Tests
11.3.2.1. Nitrazine Test
11.3.2.2. Ferning Test
11.3.2.3. Pooling
11.3.2.4. Ultrasound
11.3.2.5. Fetal Fibronectin Test
11.3.2.6. Biomarker Test
11.3.2.7. Others
11.4. Market Value Forecast, by End-user, 2020 - 2034
11.4.1. Hospitals
11.4.2. Diagnostics Laboratories
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2020 - 2034
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Test Type
11.6.2. By End-user
11.6.3. By Country/Sub-region
12. Latin America Preterm Birth and PROM Testing Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Test Type, 2020 - 2034
12.3.1. Preterm Birth Tests
12.3.1.1. Pelvic Exam
12.3.1.2. Ultrasound
12.3.1.3. Uterine Monitoring
12.3.1.4. Biomarker
12.3.2. PROM Tests
12.3.2.1. Nitrazine Test
12.3.2.2. Ferning Test
12.3.2.3. Pooling
12.3.2.4. Ultrasound
12.3.2.5. Fetal Fibronectin Test
12.3.2.6. Biomarker Test
12.3.2.7. Others
12.4. Market Value Forecast, by End-user, 2020 - 2034
12.4.1. Hospitals
12.4.2. Diagnostics Laboratories
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2020 - 2034
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Test Type
12.6.2. By End-user
12.6.3. By Country/Sub-region
13. Middle East & Africa Preterm Birth and PROM Testing Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Test Type, 2020 - 2034
13.3.1. Preterm Birth Tests
13.3.1.1. Pelvic Exam
13.3.1.2. Ultrasound
13.3.1.3. Uterine Monitoring
13.3.1.4. Biomarker
13.3.2. PROM Tests
13.3.2.1. Nitrazine Test
13.3.2.2. Ferning Test
13.3.2.3. Pooling
13.3.2.4. Ultrasound
13.3.2.5. Fetal Fibronectin Test
13.3.2.6. Biomarker Test
13.3.2.7. Others
13.4. Market Value Forecast, by End-user, 2020 - 2034
13.4.1. Hospitals
13.4.2. Diagnostics Laboratories
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2020 - 2034
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Test Type
13.6.2. By End-user
13.6.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2023)
14.3. Company Profiles
14.3.1. QIAGEN
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Financial Overview
14.3.1.5. Strategic Overview
14.3.2. Hologic, Inc.
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Financial Overview
14.3.2.5. Strategic Overview
14.3.3. Medix Biochemica
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Financial Overview
14.3.3.5. Strategic Overview
14.3.4. Biosynex SA
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Financial Overview
14.3.4.5. Strategic Overview
14.3.5. Abbott
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Financial Overview
14.3.5.5. Strategic Overview
14.3.6. Laborie
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Financial Overview
14.3.6.5. Strategic Overview
14.3.7. Sera Prognostics
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Financial Overview
14.3.7.5. Strategic Overview
14.3.8. The Cooper Companies, Inc.
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Financial Overview
14.3.8.5. Strategic Overview
14.3.9. NX Prenatal, Inc.
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Financial Overview
14.3.9.5. Strategic Overview
14.3.10. IQ Products
14.3.10.1. Company Overview
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Financial Overview
14.3.10.5. Strategic Overview

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings